Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Radi ZA and Vogel MW Gastric parietal cell atrophy and depletion after administration of a sphingosine-1-phosphate 1 inhibitor. 2014 Toxicol Pathol pmid:24178572
Nagata Y et al. Sphingosine-1-phosphate mediates epidermal growth factor-induced muscle satellite cell activation. 2014 Exp. Cell Res. pmid:24960577
Ceccom J et al. [Sphingosine 1-phosphate as a biomarker for Alzheimer's disease?]. 2014 Med Sci (Paris) pmid:24939530
Tibboel J et al. Sphingolipids in lung growth and repair. 2014 Chest pmid:24394822
Sassoli C et al. Mesenchymal stromal cell secreted sphingosine 1-phosphate (S1P) exerts a stimulatory effect on skeletal myoblast proliferation. 2014 PLoS ONE pmid:25264785
Silva VR et al. Hypothalamic S1P/S1PR1 axis controls energy homeostasis. 2014 Nat Commun pmid:25255053
Hirata N et al. Sphingosine-1-phosphate promotes expansion of cancer stem cells via S1PR3 by a ligand-independent Notch activation. 2014 Nat Commun pmid:25254944
Arnon TI and Cyster JG Blood, sphingosine-1-phosphate and lymphocyte migration dynamics in the spleen. 2014 Curr. Top. Microbiol. Immunol. pmid:24728595
Oldstone MB and Rosen H Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule. 2014 Curr. Top. Microbiol. Immunol. pmid:24728596
Martin R and Sospedra M Sphingosine-1 phosphate and central nervous system. 2014 Curr. Top. Microbiol. Immunol. pmid:24728597
Belvitch P et al. Proline-rich region of non-muscle myosin light chain kinase modulates kinase activity and endothelial cytoskeletal dynamics. 2014 Microvasc. Res. pmid:25072537
Mendes-da-Cruz DA et al. Semaphorin 3F and neuropilin-2 control the migration of human T-cell precursors. 2014 PLoS ONE pmid:25068647
Rahman MM et al. Sphingosine 1-phosphate induces neutrophil chemoattractant IL-8: repression by steroids. 2014 PLoS ONE pmid:24647471
Park SM et al. Sphingosine-1-phosphate lyase is expressed by CD68+ cells on the parenchymal side of marginal reticular cells in human lymph nodes. 2014 Eur. J. Immunol. pmid:24825162
Simmons S and Ishii M Sphingosine-1-phosphate: a master regulator of lymphocyte egress and immunity. 2014 Arch. Immunol. Ther. Exp. (Warsz.) pmid:24276789
Ni X et al. Interaction of integrin β4 with S1P receptors in S1P- and HGF-induced endothelial barrier enhancement. 2014 J. Cell. Biochem. pmid:24851274
Vanoli E et al. Vagomimetic effects of fingolimod: physiology and clinical implications. 2014 CNS Neurosci Ther pmid:24836740
Zhang GQ et al. Sphingosine-1-phosphate receptors respond differently to early myocardial ischemia and ischemia-reperfusion in vivo. 2014 Sheng Li Xue Bao pmid:24777407
Ito S et al. TNF-α production in NKT cell hybridoma is regulated by sphingosine-1-phosphate: implications for inflammation in atherosclerosis. 2014 Coron. Artery Dis. pmid:24448174
Czubowicz K and Strosznajder R Ceramide in the molecular mechanisms of neuronal cell death. The role of sphingosine-1-phosphate. 2014 Mol. Neurobiol. pmid:24420784
Kerage D et al. Review: novel insights into the regulation of vascular tone by sphingosine 1-phosphate. 2014 Placenta pmid:24411702
Chawla S et al. Exogenous sphingosine 1-phosphate protects murine splenocytes against hypoxia-induced injury. 2014 Lipids pmid:24190514
Lee H et al. 4-Deoxypyridoxine improves the viability of isolated pancreatic islets ex vivo. 2013 May-Jun Islets pmid:23756681
Egom EE et al. Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy. 2013 May-Jun Crit Rev Clin Lab Sci pmid:23885725
Ratajczak MZ et al. An emerging link in stem cell mobilization between activation of the complement cascade and the chemotactic gradient of sphingosine-1-phosphate. 2013 Jul-Aug Prostaglandins Other Lipid Mediat. pmid:22981511
Morozov VI et al. Sphingosine-1-phosphate: distribution, metabolism and role in the regulation of cellular functions. 2013 Jan-Feb Ukr Biokhim Zh (1999) pmid:23534286
Abuhusain HJ et al. A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis. 2013 J. Biol. Chem. pmid:24265321
Bolli MH et al. Novel S1P1 receptor agonists--part 1: From pyrazoles to thiophenes. 2013 J. Med. Chem. pmid:24266709
Das A et al. The promotion of mandibular defect healing by the targeting of S1P receptors and the recruitment of alternatively activated macrophages. 2013 Biomaterials pmid:24064148
Garris CS et al. Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. 2013 Nat. Immunol. pmid:24076635
Koch A et al. PPARγ agonists upregulate sphingosine 1-phosphate (S1P) receptor 1 expression, which in turn reduces S1P-induced [Ca(2+)]i increases in renal mesangial cells. 2013 Biochim. Biophys. Acta pmid:23906789
Herzog BH et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. 2013 Nature pmid:23995678
Kotani T et al. Altered expression of enzymes regulating the activity of endothelin-1 in the lower segment of the human amnion during labor. 2013 Biol. Reprod. pmid:23863409
Xiang SY et al. Lysophospholipid receptor activation of RhoA and lipid signaling pathways. 2013 Biochim. Biophys. Acta pmid:22986288
Harijith A et al. Sphingosine kinase 1 deficiency confers protection against hyperoxia-induced bronchopulmonary dysplasia in a murine model: role of S1P signaling and Nox proteins. 2013 Am. J. Pathol. pmid:23933064
Cortez-Retamozo V et al. Angiotensin II drives the production of tumor-promoting macrophages. 2013 Immunity pmid:23333075
Ono Y et al. Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration. 2013 Lipids Health Dis pmid:23418753
Bot M et al. Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice. 2013 PLoS ONE pmid:23700419
Arce FT et al. Heterogeneous elastic response of human lung microvascular endothelial cells to barrier modulating stimuli. 2013 Nanomedicine pmid:23523769
Herr DR et al. Sphingosine 1-phosphate receptors are essential mediators of eyelid closure during embryonic development. 2013 J. Biol. Chem. pmid:24003216
Dave JM et al. Proteomic profiling of endothelial invasion revealed receptor for activated C kinase 1 (RACK1) complexed with vimentin to regulate focal adhesion kinase (FAK). 2013 J. Biol. Chem. pmid:24005669
García-Bernal D et al. Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function. 2013 J. Pathol. pmid:22711564
Southern C et al. Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors. 2013 J Biomol Screen pmid:23396314
Takuwa Y et al. Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases. 2013 Biochim. Biophys. Acta pmid:22735357
Olivera A et al. Shaping the landscape: metabolic regulation of S1P gradients. 2013 Biochim. Biophys. Acta pmid:22735358
Karliner JS Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress. 2013 Biochim. Biophys. Acta pmid:22735359
Wang X et al. Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1/sphingosine 1-phosphate signaling pathway. 2013 Biochem. Pharmacol. pmid:24134913
Mierzejewska K et al. Sphingosine-1-phosphate-mediated mobilization of hematopoietic stem/progenitor cells during intravascular hemolysis requires attenuation of SDF-1-CXCR4 retention signaling in bone marrow. 2013 Biomed Res Int pmid:24490172
Ley S et al. The role of TRKA signaling in IL-10 production by apoptotic tumor cell-activated macrophages. 2013 Oncogene pmid:22410777
Polzin A et al. Aspirin inhibits release of platelet-derived sphingosine-1-phosphate in acute myocardial infarction. 2013 Int. J. Cardiol. pmid:24169533
Dziak R The role of sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA) in regulation of osteoclastic and osteoblastic cells. 2013 Immunol. Invest. pmid:24004055
Kunkel GT et al. Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. 2013 Nat Rev Drug Discov pmid:23954895
Gorshkova IA et al. Inhibition of sphingosine-1-phosphate lyase rescues sphingosine kinase-1-knockout phenotype following murine cardiac arrest. 2013 Life Sci. pmid:23892195
Beckham TH et al. Acid ceramidase promotes nuclear export of PTEN through sphingosine 1-phosphate mediated Akt signaling. 2013 PLoS ONE pmid:24098536
Xiong Y et al. Sphingosine kinases are not required for inflammatory responses in macrophages. 2013 J. Biol. Chem. pmid:24081141
Zhang W et al. ETS-1-mediated transcriptional up-regulation of CD44 is required for sphingosine-1-phosphate receptor subtype 3-stimulated chemotaxis. 2013 J. Biol. Chem. pmid:24064218
Babahosseini H et al. Bioactive sphingolipid metabolites modulate ovarian cancer cell structural mechanics. 2013 Integr Biol (Camb) pmid:24056950
Zhang O et al. Sphingosine kinase A is a pleiotropic and essential enzyme for Leishmania survival and virulence. 2013 Mol. Microbiol. pmid:23980754
Loetscher E et al. Assay to measure the secretion of sphingosine-1-phosphate from cells induced by S1P lyase inhibitors. 2013 Biochem. Biophys. Res. Commun. pmid:23499842
Moriue T et al. Sphingosine 1-phosphate attenuates peroxide-induced apoptosis in HaCaT cells cultured in vitro. 2013 Clin. Exp. Dermatol. pmid:23837937
Adada M et al. Sphingosine-1-phosphate receptor 2. 2013 FEBS J. pmid:23879641
Gao X et al. Aberrant sphingolipid metabolism in the human fallopian tube with ectopic pregnancy. 2013 Lipids pmid:23881382
Karimian G et al. Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis. 2013 Biochim. Biophys. Acta pmid:23816565
Liu Y et al. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors. 2013 J. Pathol. pmid:23839903
Riccitelli E et al. Extracellular sphingosine-1-phosphate: a novel actor in human glioblastoma stem cell survival. 2013 PLoS ONE pmid:23826381
Wang Y et al. Epidermal growth factor receptor signaling-dependent calcium elevation in cumulus cells is required for NPR2 inhibition and meiotic resumption in mouse oocytes. 2013 Endocrinology pmid:23787120
Wang Z et al. Molecular basis of sphingosine kinase 1 substrate recognition and catalysis. 2013 Structure pmid:23602659
Karapetyan AV et al. Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction. 2013 Stem Cells Dev. pmid:23282236
Kleinjan A et al. Topical treatment targeting sphingosine-1-phosphate and sphingosine lyase abrogates experimental allergic rhinitis in a murine model. 2013 Allergy pmid:23253209
Kager LM et al. Endogenous protein C has a protective role during Gram-negative pneumosepsis (melioidosis). 2013 J. Thromb. Haemost. pmid:23216621
Liang J et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. 2013 Cancer Cell pmid:23273921
Jiang LI et al. Regions on adenylyl cyclase VII required for selective regulation by the G13 pathway. 2013 Mol. Pharmacol. pmid:23229509
Park K et al. A novel role of a lipid species, sphingosine-1-phosphate, in epithelial innate immunity. 2013 Mol. Cell. Biol. pmid:23230267
Camprubí-Robles M et al. Sphingosine-1-phosphate-induced nociceptor excitation and ongoing pain behavior in mice and humans is largely mediated by S1P3 receptor. 2013 J. Neurosci. pmid:23392686
Yasuo M et al. Fenretinide causes emphysema, which is prevented by sphingosine 1-phoshate. 2013 PLoS ONE pmid:23326540
Kim YD et al. Effects of sphingosine-1-phosphate on pacemaker activity of interstitial cells of Cajal from mouse small intestine. 2013 Mol. Cells pmid:23307289
Sharma N et al. Sphingosine-1-phosphate suppresses TLR-induced CXCL8 secretion from human T cells. 2013 J. Leukoc. Biol. pmid:23345392
Salvemini D et al. Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain. 2013 Trends Pharmacol. Sci. pmid:23318139
Tibolla G et al. Class II phosphoinositide 3-kinases contribute to endothelial cells morphogenesis. 2013 PLoS ONE pmid:23320105
Lee YJ et al. Sphingosine-1-phosphate protects against bisphosphonate‑induced HUVEC cell death via regulation of c-Jun‑N‑terminal kinase signaling. 2013 Int. J. Mol. Med. pmid:23381659
Yangyuoru PM et al. Fluorescent lipids as probes for sphingosine kinase activity by capillary electrophoresis. 2013 Methods Mol. Biol. pmid:23386355
Cartwright TA et al. Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers. 2013 J. Cereb. Blood Flow Metab. pmid:23168528
Véret J et al. Role of palmitate-induced sphingoid base-1-phosphate biosynthesis in INS-1 β-cell survival. 2013 Biochim. Biophys. Acta pmid:23085009
Di Menna L et al. Fingolimod protects cultured cortical neurons against excitotoxic death. 2013 Pharmacol. Res. pmid:23073075
Zu Heringdorf DM et al. Pharmacology of the sphingosine-1-phosphate signalling system. 2013 Handb Exp Pharmacol pmid:23579459
Nguyen DH et al. Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23569284
Alberg AJ et al. Plasma sphingolipids and lung cancer: a population-based, nested case-control study. 2013 Cancer Epidemiol. Biomarkers Prev. pmid:23749868
Willis MA and Cohen JA Fingolimod therapy for multiple sclerosis. 2013 Semin Neurol pmid:23709211
Tatematsu S et al. Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium. 2013 Arterioscler. Thromb. Vasc. Biol. pmid:23723371
Guo L et al. Sphingosine-1-phosphate inhibits ceramide-induced apoptosis during murine preimplantation embryonic development. 2013 Theriogenology pmid:23731666
Zhang L et al. Sphingosine kinase 2 (Sphk2) regulates platelet biogenesis by providing intracellular sphingosine 1-phosphate (S1P). 2013 Blood pmid:23775711
Koch A et al. Sphingosine 1-phosphate in renal diseases. 2013 Cell. Physiol. Biochem. pmid:23736205
Fukuhara S and Mochizuki N [Lymphocytes mobilization into blood regulated by Spns2, a sphingosine 1-phosphate transporter, expressed on endothelial cells]. 2013 Seikagaku pmid:23717873
O'Sullivan C and Dev KK The structure and function of the S1P1 receptor. 2013 Trends Pharmacol. Sci. pmid:23763867
Chang CH et al. Sphingosine-1-phosphate induces VEGF-C expression through a MMP-2/FGF-1/FGFR-1-dependent pathway in endothelial cells in vitro. 2013 Acta Pharmacol. Sin. pmid:23377549
Cuvillier O et al. Hypoxia, therapeutic resistance, and sphingosine 1-phosphate. 2013 Adv. Cancer Res. pmid:23290779
Alshaker H et al. Therapeutic potential of targeting SK1 in human cancers. 2013 Adv. Cancer Res. pmid:23290780
Ohkuni A et al. Identification of acyl-CoA synthetases involved in the mammalian sphingosine 1-phosphate metabolic pathway. 2013 Biochem. Biophys. Res. Commun. pmid:24269233
Heffernan-Stroud LA and Obeid LM Sphingosine kinase 1 in cancer. 2013 Adv. Cancer Res. pmid:23290781
Knapp M et al. Dose-dependent effect of aspirin on the level of sphingolipids in human blood. 2013 Adv Med Sci pmid:24101372